CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Plasma and urine metabolomicsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03107819
NCT03107819N/ACompleted

Plasma and Urine Metabolomics for Biomarker Discovery in Children With Eosinophilic Esophagitis

The University of Texas Health Science Center, Houston·observational·Posted Apr 11, 2017·Updated May 1, 2018

In Brief

An observational study evaluating Plasma and urine metabolomics for Eosinophilic Esophagitis. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The investigators are seeking to enroll 8 children ages 2-18 already undergoing upper endoscopy. For the purposes of research, a peripheral blood and clean catch urine specimen will be obtained to measure plasma and urine metabolomics. The data will be used to determine if there are any key differences in the metabolite profile of subjects found to have eosinophilic esophagitis (EoE) versus non-EoE subjects. Once these metabolites are identified, the investigators will seek to enroll many more subjects for a validation phase.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 11, 2017
Enrollment StartMar 29, 2017
Primary CompletionMar 31, 2018
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 9.2 years ago

Interventions

Plasma and urine metabolomicsother

Through the use of high-pressure liquid chromatography and mass spectrometry, quantitative measurements of targeted metabolites associated with amino acids, methylation, acetylation and the tricarboxylic acid (TCA) cycle will be analyzed on the blood and urine specimens.